βk-2C-B
βk-2C-B (beta-keto 2C-B, bk-2C-B) is a psychedelic drug which is structurally related to 2C-B and BOB[1] and has been sold online as a designer drug.[2] It was found to be a polymorph and is prone to selfcondensation forming a dimer under basic to neutral conditions, similar to the reaction involved in pyrazine synthesis.[3]
Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C10H12BrNO3 |
Molar mass | 274.111 g/mol (freebase) 310.572 g/mol (HCl salt) g·mol−1 |
3D model (JSmol) | |
| |
|
Analogues and derivatives
Analogues and derivatives of 2C-B:
25-N:
- 25B-N1POMe
- 25B-NAcPip
25-NM:
- 25B-NMe7BF
- 25B-NMe7BT
- 25B-NMe7Box
- 25B-NMe7DHBF
- 25B-NMe7Ind
- 25B-NMe7Indz
- 25B-NMePyr
- 2C-B-FLY
- 2CBFly-NBOMe (NBOMe-2CB-Fly)
Other:
- 2C-B-AN
- 2C-B-BUTTERFLY
- 2C-B-DRAGONFLY-NBOH
- 2C-B-DragonFLY
- 2C-B-FLY-NB2EtO5Cl
- 2CB-5-hemifly
- 2CB-Ind
- βk-2C-B (beta-keto 2C-B)
- TCB-2 (2C-BCB)
Legal status
Canada
As of 12 October 2016, βk-2C-B became a controlled substance (Schedule III) in Canada.[4]
References
- Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, et al. (November 2004). "Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane". Journal of Medicinal Chemistry. 47 (24): 6034–41. doi:10.1021/jm040082s. PMID 15537358.
- Frison G, Odoardi S, Frasson S, Sciarrone R, Ortar G, Romolo FS, Strano Rossi S (July 2015). "Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance". Rapid Communications in Mass Spectrometry. 29 (13): 1196–204. doi:10.1002/rcm.7211. PMID 26395784.
- Power JD, Kavanagh P, O'Brien J, Barry M, Twamley B, Talbot B, et al. (June 2015). "Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B)". Drug Testing and Analysis. 7 (6): 512–8. doi:10.1002/dta.1699. PMID 25078895.
- "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Controlled Substances Act. 2016-05-04.
- "Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien" (in German). Der Bundesrat.
- "Nya substanser klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 18 August 2015.
- "Psychoactive Substances Act 2016". Home Office. Retrieved 8 September 2016.
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.